PARACHUTES: Pedophilia At Risk – Acute Treatment – E-therapy vs SSRI

Status

Not yet recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513388-16-00

Enrollment

111

Registered

2024-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pedophilic disorder

Brief summary

14 weeks from randomization

Interventions

DRUGFLUOXETINE

Eligibility

Sex/Gender

Male

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
14 weeks from randomization	—

Countries

Sweden

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026